Dr. Curry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 E Rivercenter Blvd
Covington, KY 41011Phone+1 513-618-4057
Summary
- Dr. Richard Curry is a medical director at CTI.
Clinical Expertise
- Neuro-oncology
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 2007 - 2011
- The University of Toledo College of MedicineClass of 2007
Certifications & Licensure
- OH State Medical License 2012 - 2025
- IN State Medical License 2016 - 2023
- KY State Medical License 2014 - 2023
- NY State Medical License 2011 - 2013
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 305 citationsRituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Ly...Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Jeffrey J. Raizer, David Schiff
Journal of Clinical Oncology. 2013-10-07 - 16 citationsXanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women.Karen J. Fritchie, Jorge Torres-Mora, Carrie Y. Inwards, Khin Thway, Sumathi Vaiyapuri
Modern Pathology. 2020-05-15 - 12 citationsSapC-DOPS nanovesicles: a novel targeted agent for the imaging and treatment of glioblastoma.Víctor M. Blanco, Richard Curry, Xiaoyang Qi
Oncoscience. 2015-02-09
Press Mentions
- The First Human Trials of This Experimental, Cancer-Killing Drug Could Change EverythingAugust 9th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: